Bio-matrix Scientific Group Inc (BMSN) financial statements (2020 and earlier)

Company profile

Business Address 1204 TANGERINE ST
EL CAJON, CA 92021-5011
State of Incorp. DE
Fiscal Year End July 31
SIC 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2020
Q2
10/31/2019
Q1
9/30/2016
Q4
6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1128142119193
Cash and cash equivalents1128142119193
Receivables  83   
Prepaid expense  85161616
Other undisclosed current assets 730292929
Total current assets:18225187164238
Noncurrent Assets
Other undisclosed noncurrent assets13331178561125
Total noncurrent assets:13331178561125
TOTAL ASSETS:1441342272225363
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities001,9201,6741,4181,346
Accounts payable  383290163170
Accrued liabilities  5555
Employee-related liabilities  1,1531,014900833
Interest and dividends payable00379365350338
Debt  10710358559
Due to related parties10101111
Other undisclosed current liabilities857543256959960
Total current liabilities:95852,4602,3472,0761,965
Noncurrent Liabilities
Long-term debt and lease obligation  10710358 
Long-term debt, excluding current maturities  10710358 
Total noncurrent liabilities:  10710358 
Total liabilities:95852,5672,4502,1341,965
Stockholders' equity
Stockholders' equity attributable to parent, including:(81)(44)(2,637)   
Preferred stock000   
Common stock1,5621,562656   
Additional paid in capital0036,330   
Accumulated other comprehensive loss  (47)   
Accumulated deficit(1,644)(1,607)(40,086)   
Other additional capital11509   
Other undisclosed stockholders' equity attributable to parent00    
Stockholders' equity attributable to noncontrolling interest  44818152195
Other undisclosed stockholders' equity  (35)(2,358)(1,961)(1,797)
Total stockholders' equity:(81)(44)(2,225)(2,177)(1,909)(1,602)
TOTAL LIABILITIES AND EQUITY:1441342272225363

Income statement (P&L) ($ in thousands)

1/31/2020
Q2
10/31/2019
Q1
9/30/2016
Q4
6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
Revenues69100   
Loss on disposition of assets for financial service operations(20)(15)
Cost of revenue  (289)(236)(130)(108)
Gross profit:69(189)(236)(130)(108)
Operating expenses(27)(36)(523)(676)(639)(626)
Other undisclosed operating income109    
Operating loss:(10)(18)(712)(912)(769)(734)
Nonoperating income (expense)(27)(15)0000
Investment income, nonoperating  0000
Other nonoperating expense(27)(15)    
Interest and debt expense(0)(0)(17)(17)(13)(13)
Net loss:(38)(33)(728)(928)(781)(746)
Net loss attributable to noncontrolling interest  (2,228)(2,051)(927)(1,567)
Other undisclosed net income attributable to parent00    
Net loss available to common stockholders, diluted:(37)(33)(2,956)(2,979)(1,708)(2,313)

Comprehensive Income ($ in thousands)

1/31/2020
Q2
10/31/2019
Q1
9/30/2016
Q4
6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
Net loss:(38)(33)(728)(928)(781)(746)
Comprehensive loss:(38)(33)(728)(928)(781)(746)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (1,809)(1,486)(580)(1,445)
Comprehensive loss, net of tax, attributable to parent:(38)(33)(2,537)(2,414)(1,362)(2,191)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: